NCT06696469

Brief Summary

The aim of this study is to demonstrate the feasibility and reliability of using virtual reality-based BeCureTM in the assessment of upper extremity motor functions in stroke patients.It is necessary to define the appropriate patient profile for the evaluation of upper extremity motor functions in stroke patients with virtual reality method. We aimed to examine the effects of demographic characteristics, accompanying cognitive disorders and upper extremity motor disorders that may affect the evaluation and response to treatment on virtual reality applications. Therefore, BeCure TM virtual reality system can be feasibly used in the evaluation and rehabilitation of stroke patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for all trials

Timeline
1mo left

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Jun 2024Jun 2026

Study Start

First participant enrolled

June 22, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 14, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 20, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 22, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2026

Last Updated

November 22, 2024

Status Verified

November 1, 2024

Enrollment Period

2 years

First QC Date

November 14, 2024

Last Update Submit

November 20, 2024

Conditions

Keywords

upper limb motor functionsstrokevirtual reality

Outcome Measures

Primary Outcomes (1)

  • The feasibility of using BeCureTM virtual reality in stroke patients will be determined according to the System Usability Scale (SUS) score.

    The System Usability Scale (SUS) is a simple, ten-item Likert scale of subjective evaluations of usability. It was developed in 1986 by John Brooke for usability evaluation. In short, it is a standardized questionnaire to measure users' satisfaction with a product or system. At the same time, a score between 0-100 can be obtained with SUS. When calculating the exact score, 1 is subtracted from the given value of items 1, 3, 5, 7 and 9 (odd numbered and positive opinion). The scores for items 2, 4, 6, 8 and 10 (items with negative opinions) are subtracted from 5. The SUS score can then be found by adding them all together and multiplying this sum by 2.5 to complete the 0-100 range. The minimum score is 0 points and the maximum score is 100 points. A higher score indicates better usability.

    Baseline and 7 days

Secondary Outcomes (1)

  • 1- A patient feedback questionnaire on the safety of BeCureTM virtual reality use will be completed.

    Baseline and 7 days

Study Arms (1)

Patient group

Post-stroke patients

Diagnostic Test: Feasibility and reliability of using BeCureTM Virtual Reality in the evaluation of upper extremity motor functions in stroke patients

Interventions

The applicability and reliability of virtual reality systems are important factors to consider. Based on this, this study aimed to investigate the feasibility of using BeCureTM virtual reality in the evaluation of upper extremity functions after stroke.The feasibility of using BeCureTM virtual reality in stroke patients will be determined according to the System Usability Scale (SUS) score.The safety of the use of BeCureTM virtual reality in stroke patients will be assessed with a patient feedback questionnaire. The relationship between the use of BeCureTM virtual reality and cognitive functions in stroke patients will be determined by the Montreal Cognitive Assessment Scale and Mini Mental State Examination.It was aimed to examine the effects of demographic characteristics, accompanying cognitive disorders and upper extremity motor disorders that may affect the evaluation and response to treatment on virtual reality applications.

Patient group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Post-stroke patients consecutively admitted to Ankara University Faculty of Medicine, Department of Physical Medicine and Rehabilitation will be included in the study.

You may qualify if:

  • Patients diagnosed with stroke according to the World Health Organization with an age range of 18-80 years
  • Patients with subacute to chronic stroke
  • Patients who can understand commands
  • Patients with sitting balance
  • Patients with a first stroke attack
  • Patients who have never received virtual reality therapy
  • Upper extremity Brunnstrom Stage III and above
  • Patients with a spasticity level below 3 according to the Modified Ashworth Scale (MAS) in the affected upper extremity (MAS 1-5 rating system)
  • Patients who agreed to participate in the study and signed the informed consent form

You may not qualify if:

  • History of seizures or epilepsy (except childhood febrile seizures),
  • Arthritis or pain in the affected upper limb that limits repetitive exercise,
  • Severe aphasia, cognitive impairment (premorbid dementia) or psychiatric disorders,
  • Spasticity in the affected arm is 3 or more compared to MAS,
  • Patients without sitting balance,
  • Patients with posterior cerebral artery infarction,
  • Patients with subarachnoid hemorrhage,
  • Patients with visual impairments that may affect the virtual reality application

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara University School of Medicine Department of Physical Medicine and Rehabilitation

Ankara, 06620, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Sehim Kutlay, Professor

    Ankara University

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Doctor

Study Record Dates

First Submitted

November 14, 2024

First Posted

November 20, 2024

Study Start

June 22, 2024

Primary Completion (Estimated)

June 22, 2026

Study Completion (Estimated)

June 22, 2026

Last Updated

November 22, 2024

Record last verified: 2024-11

Locations